No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
RXST RxSight
- 51.955
- -0.885-1.67%
Trading Apr 25 13:33 ET
1.92BMarket Cap-36847P/E (TTM)
52.165High50.420Low104.56KVolume51.840Open52.840Pre Close5.36MTurnover0.38%Turnover RatioLossP/E (Static)36.99MShares58.21052wk High11.98P/B1.45BFloat Cap17.59452wk Low--Dividend TTM27.81MShs Float58.210Historical High--Div YieldTTM3.30%Amplitude8.800Historical Low51.297Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Should You Investigate RxSight, Inc. (NASDAQ:RXST) At US$52.84?
RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
ALISO VIEJO, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,
Companies Like RxSight (NASDAQ:RXST) Can Afford To Invest In Growth
We can readily understand why investors are attracted to unprofitable companies. Indeed, RxSight (NASDAQ:RXST) stock is up 197% in the last year, providing strong gains for shareholders. But while
Needham Sees BSX, CNMD, RMD Beating Street, Despite Medtech Slow Down
Assessing RxSight: Insights From 8 Financial Analysts
RxSight (NASDAQ:RXST) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.Summarizing their recent assessments, the table below illustrates
Express News | Needham Reiterates Buy on RxSight, Maintains $64 Price Target
Comments
The recent insider sale of RxSight shares and the absence of insider purchases over the last year raise concerns about the company's outlook. Despite significant insider ownership, the lack of insider buying does not inspire confidence in the company's prospects.
Trade Alert: Independent Director Of RxSight William Link Has Sold Stock
$RxSight(RXST.US$ oww back in action now sold too early
3
2
making new high watching closely$RxSight(RXST.US$ 213 % runs looks good here priming to jump 🔥
1
$RxSight(RXST.US$ bought few lets fo !
1
Stocks making the biggest moves before the bell:
$Tesla(TSLA.US$ — Shares fell 1.2% after U.S. safety regulators said Tesla will recall more than 2 million vehicles to fix issues with its driver assistance system. The electric vehicle maker will send out a software update to fix the problem, which impacts models Y, S, 3 and X produced between Oct. 5, 2012 and Dec. 7, 2023. $Pfizer(PFE.US$ — The biopharmaceutical stock dropped 7.4% after Pfizer issued full-year guidance for adjusted earnings ... 2
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg